25,000 volunteers help scientists track COVID, flu, and RSV in real time
NCT ID NCT07147517
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand how common respiratory viruses like COVID-19, flu, and RSV spread in communities. Researchers will track up to 25,000 people of all ages using at-home test kits and symptom surveys. The goal is to better predict outbreaks and improve public health responses, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide crucial data to better predict and prepare for future respiratory virus outbreaks.
- What could go wrong
- This is an observational study, not a treatment trial. It won't directly cure or prevent illness, and results depend on accurate self-reporting and participation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 25,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Oct 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Investigators will include a large portion of San Diego County, which resides in HHS Region 9 and is the Southwestern-most county in the continental U.S, abutting the U.S./Mexico border.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Community Testing Component: Inclusion: \- All community members are able to participate in the community testing component. Exclusion: \- There is no exclusion criteria and participants will not be excluded based on pregnancy status or age. For Component A: Inclusion: * All ages * AND Lives in service area of a recruitment center (i.e., within range of courier pick up) * AND Plans to remain living in a recruitment area for the next 2 years. Exclusion: * Inability to communicate in a language in which consent forms, materials, etc. are available * OR Incarcerated * OR Living in a congregate setting (e.g., assisted living, nursing home, university dormitories with shared bathroom and communal eating facilities) * OR Unable/unwilling to participate in planned data and specimen collections * OR Unable to comply with study procedures, as determined by study investigators * OR Participation in clinical trials of investigational agents for respiratory viral infections during the three months prior to enrollment and for the duration of the study. For Component B: Inclusion: Index case: * Detection of priority respiratory pathogen via laboratory or point-of-care test on the day of eligibility screening or in the previous 5 days, AND * Lives in service area of a recruitment center (i.e., within range of courier pick up), AND * Lives in a household with ≥1 other person and plans to remain in the household for at least the duration of specimen collection (i.e., 14 days), AND * Has not been hospitalized since the date of symptom onset. Household contacts: * Routinely sleep in the same household as index case and slept in household ≥1 night in the 7 days before index case symptom onset, AND * Plan to remain in the household for at least the duration of specimen collection (i.e., 14 days). Household: * There is ≥1 non-ill household member (i.e., asymptomatic and has not tested positive for the virus of the index case) on the day of eligibility screening or in the previous 5 days, * AND all symptomatic persons in the household had a symptom or diagnosis onset date on the day of eligibility screening or in the previous 5 days. Exclusion: Index case: * Lives in a congregate setting (e.g., assisted living, nursing home, university dormitories with shared bathroom and communal eating facilities) * Meet any A1 exclusion criteria Household contacts: * Has been hospitalized any time since date of primary case symptom onset * Meets any A1 exclusion criteria Household: * The enrollment visit occurs \>6 days after the first symptom onset of primary case * The primary case in the household is not enrolled * The primary case has been hospitalized any time after the date of symptom onset
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID -19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
San Ysidro Health
RECRUITINGSan Ysidro, California, 92173, United States
-
UC San Diego
RECRUITINGLa Jolla, California, 92093, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home antibody tests put to the test: can you read your own COVID-19 result?
- Can lung ultrasound reveal COVID-19's signature in the lungs?
- When the immune system Can't fight back: tracking three respiratory viruses
- The household maze: how does COVID-19 move between family members?
- Can an oral drug stop COVID-19 from turning deadly?
- Can COVID-19 rapid tests slip into HIV and TB clinics without disrupting care?